secwatch.observer — SEC 8-K summary
======================================

Issuer:     Eloxx Pharmaceuticals, Inc. (ELOX)
CIK:        0001035354
Form:       8-K
Filed at:   2022-01-05T23:59:59+00:00
Accession:  0001104659-22-001026
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Eloxx receives Nasdaq deficiency notice for bid price below $1.00; 180-day cure period until July 5, 2022
--------------------------------------------------------------------------------

- Closing bid price of common stock below $1.00 for 30 consecutive business days as of Jan 3, 2022.
- Company has until July 5, 2022 to regain compliance; may qualify for an additional 180-day grace period.
- Options to cure include a reverse stock split; no assurance of regaining compliance.
- Stock continues trading on Nasdaq Global Market under symbol ELOX during the cure period.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1035354/000110465922001026/0001104659-22-001026-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1035354/000110465922001026/tm221588d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-001026

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer